Citadel Advisors LLC 13D and 13G filings for Vera Therapeutics, Inc.:
- Schedule 13D must be filed within ten days after a person or an organization acquires beneficial ownership of more than 5% of a voting class of a company's equity securities.
- Shares have been adjusted for stock splits.
| Reported DateTime |
Transaction Date |
Type | Company Symbol |
Filed By Symbol |
Shares Owned % Owned |
Shares Vs. Prev Report | View |
| 2024-02-14 4:57 pm Sale |
2023-12-31 | 13G | Vera Therapeutics, Inc. VERA |
Citadel Advisors LLC | 43,447 0.100% |
-1,948,106 (-97.82%) |
Filing |
| 2023-02-14 08:02 am Sale |
2022-12-31 | 13G | Vera Therapeutics, Inc. VERA |
Citadel Advisors LLC | 1,991,553 7.200% |
-50,867 (-2.49%) |
Filing |
| 2022-02-14 06:30 am Purchase |
2021-12-31 | 13G | Vera Therapeutics, Inc. VERA |
Citadel Advisors LLC | 2,042,420 9.600% |
17,370 (+0.86%) |
Filing |
| 2021-05-28 4:17 pm Purchase |
2021-05-18 | 13G | Vera Therapeutics, Inc. VERA |
Citadel Advisors LLC | 2,025,050 9.900% |
2,025,050 (New Position) |
Filing |